Overview

A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV Drugs

Status:
Completed
Trial end date:
1999-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety of didanosine plus stavudine plus nelfinavir (NLF) with that of zidovudine plus lamivudine plus NLF. This study also examines how long these drug combinations are effective in lowering viral load (level of HIV in the blood).
Phase:
N/A
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
Didanosine
Lamivudine
Nelfinavir
Stavudine
Zidovudine